- Home
- ALGS vs IPSC Comparison
ALGS vs IPSC Comparison
Compare ALGS & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- IPSC
- Stock Information
- Founded
- ALGS 2018
- IPSC 2019
- Country
- ALGS United States
- IPSC United States
- Employees
- ALGS N/A
- IPSC N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- ALGS Health Care
- IPSC Health Care
- Exchange
- ALGS Nasdaq
- IPSC Nasdaq
- Market Cap
- ALGS 56.7M
- IPSC 49.1M
- IPO Year
- ALGS 2020
- IPSC 2021
- Fundamental
- Price
- ALGS $9.74
- IPSC $0.54
- Analyst Decision
- ALGS Strong Buy
- IPSC Strong Buy
- Analyst Count
- ALGS 2
- IPSC 6
- Target Price
- ALGS $60.00
- IPSC $3.00
- AVG Volume (30 Days)
- ALGS 90.2K
- IPSC 1.5M
- Earning Date
- ALGS 11-06-2025
- IPSC 11-13-2025
- Dividend Yield
- ALGS N/A
- IPSC N/A
- EPS Growth
- ALGS N/A
- IPSC N/A
- EPS
- ALGS N/A
- IPSC N/A
- Revenue
- ALGS $2,646,000.00
- IPSC $113,337,000.00
- Revenue This Year
- ALGS N/A
- IPSC $1,589.94
- Revenue Next Year
- ALGS N/A
- IPSC N/A
- P/E Ratio
- ALGS N/A
- IPSC N/A
- Revenue Growth
- ALGS N/A
- IPSC 4122.69
- 52 Week Low
- ALGS $3.76
- IPSC $0.34
- 52 Week High
- ALGS $46.80
- IPSC $1.83
- Technical
- Relative Strength Index (RSI)
- ALGS 62.50
- IPSC 51.52
- Support Level
- ALGS $5.81
- IPSC $0.46
- Resistance Level
- ALGS $7.00
- IPSC $0.52
- Average True Range (ATR)
- ALGS 0.79
- IPSC 0.04
- MACD
- ALGS 0.38
- IPSC -0.00
- Stochastic Oscillator
- ALGS 88.61
- IPSC 71.52
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.